These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23522631)

  • 1. Topical treatment of hyperpigmentation disorders.
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topical treatment of hyperpigmentation disorders].
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S102-7. PubMed ID: 23260517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and emerging treatments for hyperpigmentation.
    Alexis AF
    J Drugs Dermatol; 2014 Apr; 13(4):382-5. PubMed ID: 24719055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperpigmentation.
    Woolery-Lloyd H; Kammer JN
    Semin Cutan Med Surg; 2011 Sep; 30(3):171-5. PubMed ID: 21925372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermocosmetic management of hyperpigmentations.
    Guerrero D
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S166-9. PubMed ID: 23522633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroquinone: myths and reality.
    Searle T; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2021 Jun; 46(4):636-640. PubMed ID: 33159818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical retinoids for pigmented skin.
    Geria AN; Lawson CN; Halder RM
    J Drugs Dermatol; 2011 May; 10(5):483-9. PubMed ID: 21533293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural options for the management of hyperpigmentation.
    Leyden JJ; Shergill B; Micali G; Downie J; Wallo W
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1140-5. PubMed ID: 21623927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
    Boissy RE; Visscher M; DeLong MA
    Exp Dermatol; 2005 Aug; 14(8):601-8. PubMed ID: 16026582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone.
    Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2013 Jan; 12(1):52-8. PubMed ID: 23377328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hyperpigmentation.
    Rossi AM; Perez MI
    Facial Plast Surg Clin North Am; 2011 May; 19(2):313-24. PubMed ID: 21763992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies.
    Sonthalia S; Daulatabad D; Sarkar R
    Indian J Dermatol Venereol Leprol; 2016; 82(3):262-72. PubMed ID: 27088927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical agents used in the management of hyperpigmentation.
    Halder RM; Richards GM
    Skin Therapy Lett; 2004; 9(6):1-3. PubMed ID: 15334278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
    Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
    J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized control trial outcomes of tranexamic acid combination serum as a depigmenting agent for the use in healthy individuals.
    Anwar AI; Wahab S; Widita W; Nurdin AR; Budhiani S; Seweng A
    Dermatol Ther; 2019 Nov; 32(6):e13146. PubMed ID: 31664751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatments for melasma and postinflammatory hyperpigmentation.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin lightening preparations and the hydroquinone controversy.
    Draelos ZD
    Dermatol Ther; 2007; 20(5):308-13. PubMed ID: 18045355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Anti-Aging South Korean Cosmeceuticals.
    Quay ER; Chang YC; Graber E
    J Drugs Dermatol; 2017 Apr; 16(4):358-363. PubMed ID: 28403270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.
    Draelos ZD
    J Am Acad Dermatol; 2015 Jan; 72(1):105-7. PubMed ID: 25440437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.